ProfileGDS4718 / 227086_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 67% 64% 79% 65% 70% 69% 70% 66% 69% 68% 68% 68% 73% 68% 71% 68% 71% 76% 70% 70% 65% 67% 68% 70% 68% 71% 68% 73% 65% 72% 70% 69% 68% 70% 70% 70% 72% 65% 69% 76% 65% 70% 69% 73% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.6290667
GSM549102patient 115, normal, homogenized [OPG study]6.394264
GSM549104patient 119, normal, homogenized [OPG study]7.8458979
GSM549108patient 138, normal, homogenized [OPG study]6.5084565
GSM549119patient 077, normal, homogenized [OPG study]6.8374170
GSM549133patient 032, cancer, homogenized [OPG study]6.8290569
GSM549139patient 042, cancer, homogenized [OPG study]6.8796170
GSM549099patient 107, normal, homogenized [OPG study]6.5226966
GSM549109patient 139, normal, homogenized [OPG study]6.7481769
GSM549110patient 046, normal, homogenized [OPG study]6.6837668
GSM549114patient 063, normal, homogenized [OPG study]6.6516668
GSM549122patient 082, normal, homogenized [OPG study]6.7341168
GSM549134patient 033, cancer, homogenized [OPG study]7.1751973
GSM549136patient 036, cancer, homogenized [OPG study]6.717668
GSM549140patient 044, cancer, homogenized [OPG study]6.9919971
GSM549111patient 047, normal, homogenized [OPG study]6.7355968
GSM549113patient 057, normal, homogenized [OPG study]6.9504171
GSM549132patient 031, cancer, homogenized [OPG study]7.5062576
GSM549137patient 038, cancer, homogenized [OPG study]6.9023270
GSM549142patient 047, cancer, homogenized [OPG study]6.812670
GSM549100patient 110, normal, homogenized [OPG study]6.4605665
GSM549107patient 135, normal, homogenized [OPG study]6.6218767
GSM549115patient 068, normal, homogenized [OPG study]6.6815968
GSM549116patient 072, normal, homogenized [OPG study]6.8634370
GSM549120patient 078, normal, homogenized [OPG study]6.7149168
GSM549131patient 030, cancer, homogenized [OPG study]7.0792871
GSM549118patient 074, normal, homogenized [OPG study]6.7084768
GSM549129patient 027, cancer, homogenized [OPG study]7.190773
GSM549123patient 088, normal, homogenized [OPG study]6.4843365
GSM549124patient 006, cancer, homogenized [OPG study]7.0430872
GSM549126patient 015, cancer, homogenized [OPG study]6.865570
GSM549128patient 025, cancer, homogenized [OPG study]6.8308869
GSM549103patient 117, normal, homogenized [OPG study]6.6602968
GSM549117patient 073, normal, homogenized [OPG study]6.8203970
GSM549138patient 041, cancer, homogenized [OPG study]6.9007970
GSM549141patient 045, cancer, homogenized [OPG study]6.9754270
GSM549130patient 028, cancer, homogenized [OPG study]7.0697572
GSM549101patient 111, normal, homogenized [OPG study]6.5159565
GSM549105patient 128, normal, homogenized [OPG study]6.7930469
GSM549106patient 134, normal, homogenized [OPG study]7.6161576
GSM549112patient 048, normal, homogenized [OPG study]6.4541465
GSM549125patient 011, cancer, homogenized [OPG study]6.8465370
GSM549127patient 024, cancer, homogenized [OPG study]6.8863169
GSM549135patient 035, cancer, homogenized [OPG study]7.2188573